The main medication classes prescribed for the treatment of MDD, the selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs), directly bind to and modulate [7] the serotonin transporter (SERT). The gene discussed is SLC6A4; the disease is major depressive disorder.